Professional Documents
Culture Documents
Electrolytes
Electrolytes
Presented by
Outline
General Physiology and Laboratory Analysis of Electrolytes
Electrolyte – Chemistry and Biological Functions
Overview of Electrolyte Determination in the Clinical Laboratory
Specimen Collection and Processing
Instrumentation and Analytical Methodologies
Trends seen in some diseases associated with electrolytes
Anion Gap
Water Distribution & Physiology
Total Body Water
Water Homeostasis
Plasma osmolality
Sodium
Potassium
Chloride
Bone and Mineral Metabolism
Bone and Mineral Metabolism
Calcium
Phosphate
Magnesium
General Physiology &
Laboratory Analysis
4
Electrolytes
Electrolytes
Intracellular Extracellular
Cations Cations
K+ Na+
Mg2+ Ca2+
Anions Anions
PO43- Cl-
6
Acid-Base Homeostasis
Potassium, Chloride, Bicarbonate
Blood Coagulation
Calcium, Magnesium
Neurotransmitter Excitability
Potassium, Calcium, Magnesium
ATP Usage and Production
Magnesium, Phosphates
8
Electrolyte Determination
Electrolyte Profile
Na+, K+, Cl-, HCO3-
Serum or Urinary Calcium
Total Calcium
Ionized Calcium (Serum only)
Serum or Urinary Magnesium
Serum or Urinary Phosphates
Sweat Chloride
9
Electrolyte Determination
Urine
24-hr urine – preferred specimen
No Preservative : Na+, K+, Cl-
Acidified Urine : Ca2+, Mg2+, Phosphates
Sweat
For chloride testing ; at least 100 mg
Two-step collection procedure
Pilocarpine Iontophoresis – stimulation for 5 mins
Sweat Collection by using either :
Filter Paper or Gauze (Gibson-Cooke Method)
Plastic Microbore Tubing
14
Potassium
Valinomycin
Bis(benzyl-15-crown-5)-heptanedoate
Sodium
Methylmonensin
ETH 157 and 227
Glass Aluminum silicate
Chloride
Tri-n-octylpropylammonium chloride
Tributylin
Mercuracarborand-3 (MC3) – liquid membrane
Calcium
ETH 1001
Calcimycin
Liquid Membrane : 2-ethylhexyl phosphoric acid in dioctyl phenyl phosphonate
16
Amperometry
Voltametric technique
involves application of a constant reducing or oxidizing potential to an indicator
(working) electrode and the subsequent measurement of the resulting steady-
state current
Coulometry
measures the electrical charge passing between two electrodes in an
electrochemical cell
Amount of charge (coulomb) passing between the electrodes is directly
proportional to
oxidation or reduction of an electroactive substance at one of the electrodes
Absolute method; gold standard for serum/plasma chloride determination
18
Amperometric-Coulometric Titration
20
Renal Failure
Increased K+, Mg2+, PO43-, Ca2+
Decreased Na+
Hyperaldosteronism
Increased Na+, Cl-
Decreased K+, Mg2+
Hyperparathyroidism
Increased Ca2+
Decreased PO43-
Alkalosis
Decreased K+, Ca2+
21
Anion Gap
75% Interstitial
1/3 ECF
25% Intravascular
2/3 ICF
24
Water Homeostasis
Electrolytes involved : Na+, K+, Cl-
Law of Electroneutrality
the sum of positive and negative charges within the water must balance
to zero (ECF charge = ICF Charge)
Na+ = primary ECF cation
K+ = primary ICF cation ; countercurrent ion of sodium
Cl- = primary ECF anion ; counterion of sodium
PO43- = primary ICF anion
Gibbs-Donan Eqilibrium
If solutions on two sides of a membrane contain different [ions] that
cannot freely move through the membrane (e.g., proteins), distribution of
diffusible ions at the steady state will be unequal but
the sum of [ions] in one compartment is equal to the other
compartment
25
Gibbs-Donnan Equilibrium
Volume Regulation
Salt content
Chief determinant of extracellular volume
Effective Vascular Volume
Chief determinant of how much ECF is retained
Arginine Vasopressin Peptide (AVP)
(Antidiuretic Hormone)
Promotes water retention
Baroreceptors in carotid sinus, atria of heart,
and aortic arch send neural signals to CNS
resulting in an increase or a decrease in AVP
secretion
Aldosterone
Promotes sodium retention
27
Volume Regulation
Natriuretic Peptides : promotes sodium excretion
Atrial Natriuretic Peptide – produced by the atrium
Brain Natriuretic Peptide – produced by the heart ventricles
Marker of heart failure
Urodilatin
Most important natriuretic peptide for renal excretion of sodium
Water Homeostasis
29
Plasma Osmolality
Loop of Henle
Na+-K+-Cl- Cotransporter (NKCC) aids in secondary active transport of
these ions into cells
AVP creates osmotic gradient that enables water reabsorption to be
increased or decreased in response to fluid changes in osmolality.
Collecting Ducts
Under AVP influence ; final adjustment of water excretion
33
Sodium
Major extracellular cation
Major contributor of osmolality
Concentration largely depends on water
Reabsorption is stimulated by
aldosterone
Excretion is stimulated by ANP
Counterbalanced by Cl-
Countercurrent exchange with K+
Na+/K+-ATPase pump: 3Na+ Out, 2K+ In
Reabsorbed in exchange for K+ or H+
Reference Interval
135 mmol/L to 145 mmol/L
34
Hyponatremia
Most common electrolyte disorder
Clinical definition : plasma sodium level < 135 mmol/L
Clinical concern arises when plasma sodium drops to < 130 mmol/L
Clinical Manifestations
Nausea and generalized weakness
Mental confusion (< 120 mmol/L)
Severe mental confusion, seizures (< 105 mmol/L)
Correction must be performed gradually (0.5-2.0 mmol/L/hr)
May cause brain demyelination if too rapid
Classifications
Hypo-osmotic
Iso-osmotic
Hyperosmotic
35
Hypo-osmotic Hyponatremia
May be due to :
Excess loss of Na+ (depletional hyponatremia) – hypovolemic (most common)
Increased ECF volume (dilutional hyponatremia) - hypervolemic
Depletional hyponatremia
Extrarenal Loss : Urine Na+ < 10 mmol/L
GI Loss : Vomiting, Diarrhea
Skin loss : Burns, Sweating
Renal Loss ; Urine Na+ > 20 mmol/L
Diuretics use
Mineralocorticoid deficiency
Metabolic alkalosis : increased HCO3- excretion is accompanied by Na+
Proximal RTA : defective HCO3- reabsorption, Na+ lost along with HCO3-
Ketonuria : lost alongside Ketones
Carbonic anhydrase inhibitors
Salt-losing renal diseases
Polycystic kidney, Chronic interstitial nephritis, obstruction
36
Hypo-osmotic Hyponatremia
High ECF ;
baroreceptors
Dilutional hyponatremia Low BV
High Urinary Na+
Renal Failure
Low Urinary Na+
Congestive Heart Failure
Cirrhosis with ascites
Nephrotic syndrome Intravascular fluid Increase aldosterone
moves to tissues and vasopressin
Hypo-osmotic Hyponatremia
Euvolemic Hypo-osmotic Hyponatremia
Syndrome of inappropriate ADH secretion
(SIADH)
Malignant, Inappropriate vasopressin release
leading to excessive water retention
Primary polydipsia (psychiatric or hypothalamic
as seen in sarcoidosis)
Hypothyroidism
Impaired free water excretion
Hypoadrenalism
Low aldosterone high cortisol-releasing
hormone
CRH stimulates vasopressin
38
Iso-osmotic Hyponatremia
Causes
Pseudohyponatremia
Electrolyte exclusion effect
Hemolysis
Increased non-sodium cations
Lithium excess
Increased gamma-globulins
Severe hyperkalemia
Severe hypermagnesemia
Severe hypercalcemia
39
Hyperosmotic Hyponatremia
Causes
Severe hyperglycemia
For every 100 mg/dL increase in glucose level that is above 100 mg/dL, Na+
decreases by 1.6-2.0 mmol/L
Mannitol and glycine infusion
Uremia
40
Hypernatremia
Clinical definition : plasma Na+ > 150 mmol/L
Always hyperosmolar
Symptoms : Ataxia, tremors, irritability, confusion, coma
Acute Hypernatremia : symptoms at 160 mmol/L
Chronic Hypernatremia : symptoms may not occur until Na+ exceeds 175 mmol/L
Rapid correction may induce to cerebral edema and death
Classifications
Hypovolemic Hypernatremia
Euvolemic Hypernatremia
Hypervolemic Hypernatremia
41
Hypovolemic Hypernatremia
Dehydration with or without sodium excess
Extrarenal loss of water coupled with failure to replace water
Urine Na+ <10 mmol/L, Hypertonic Urine
Diarrhea
Burns
Fever
Excessive sweating
Renal loss
Osmotic diuresis
Hyperglycemic nonketotic syndrome – common in T1DM patients with glucose
> 600 mg/dL
42
Euvolemic Hypernatremia
Often a prelude to hypovolemic hypernatremia
Causes
Diabetes insipidus : Hypotonic urine
Central DI : decreased or absent vasopressin
Head trauma, hypophysectomy, pituitary tumor, granulomatous disease
Nephrogenic DI- renal resistance to vasopressin
Excessive drug use: lithium, demeclocycline, amphotericin,
propoxyphene
Hypercalcemia
Hypokalemia
Sickle cell anemia
Sjogren syndrome
Mutated vasopressin receptor
Increased insensible loss of water : Hypertonic urine
43
Hypervolemic Hypernatremia
Water excess with a large Na+ excess
Causes
Hyperaldosteronism
Cushing syndrome (Primary Hypercortisolism)
Hypertonic IV fluid therapy
44
Sodium Determination
Direct/Indirect ISE – Glass aluminum silicate
Most widely used
AAS
Flame-emission spectrophotometry – obsolete
Lithium as internal standard
Spectrophotometry
Kinetic Assay using β-galactosidase
Sodium activates the enzyme
Substrate : o-nitrophenyl-β-D-galactopyranoside
Product : o-nitrophenol
Measured at 420 nm
45
Potassium
Major intracellular cation; Excretion is promoted by aldosterone
Countercurrent ion of Na+
Counter-exchange ion of H+
For every 0.1 unit drop in pH, plasma K+ increases by 0.2-0.5 mmol/L
Intracellular concentration is 20x greater than plasma concentration
Entry to skeletal muscle cells & hepatocytes promoted by insulin
Cellular entry promoted by catecholamines, inhibited by propanolol
Exercise increases plasma K+ by 0.3 to 1.2 mmol/L
May increase up to 2-3 mmol/L if exhaustive exercise
Reversed after several minutes of rest
Reference Interval – narrow, any deviation is life threatening
Serum : 3.5 – 5.1 mmol/L
Plasma : 3.5 – 4.5 mmol/L (M) ; 3.4 – 4.4 mmol/L (F)
46
Hypokalemia
Plasma K+ < 3.5 mmol/L
Signs and Symptoms : muscle weakness, irritability, paralysis
< 3 mmol/L : neuromuscular symptoms ; critical intracellular depletion
Lower concentrations : tachycardia, flattened T-waves on ECG
May lead to cardiac arrest
Classification
K+ Redistribution-related Hypokalemia – transient
Insulin response
Alkalosis
Catecholamine or B-adrenergic excess
Leukocytosis (pseudohypokalemia)
Hypothermia
Hypokalemic periodic paralysis
True K+ deficit Hypokalemia
Renal cause
Nonrenal cause
47
Hypokalemia
True K+ deficit Hypokalemia with > 25 mmol/day Urine K+
Renal loss
Acute Tubular Necrosis – diuretic phase
Amphotericin B toxicity
Hypomagnesemia
Metabolic Alkalosis : H+ reabsorbed in exchange for K+
w/ Urine Cl- >10 mmol/d
Mineralocorticoid excess
Cushing syndrome
w/ Urine Cl- <10 mmol/d
Diuretics
Vomiting
Penicillin
Renal Tubular Acidosis
Bartter syndrome
Gitelman syndrome
48
Hypokalemia
True K+ deficit Hypokalemia with < 25 mmol/day Urine K+
Extrarenal loss
Diarrhea
Fistula
Excessive sweating
Decreased dietary intake
Starvation
49
Hyperkalemia
Plasma K+ > 5 mmol/L
Signs and symptoms
mental confusion, weakness, tingling, flaccid paralysis of extremities
>6.5 mmol/L : bradycardia, prolonged PR & QRS intervals, peaked T-waves on ECG
>7.0 mmol/L – peripheral vascular collapse, cardiac arrest
>10.0 mmol/L – absolute fatality
Result of (singly or in combination) :
Redistribution
Increased intake
Increased retention
50
Hyperkalemia
Redistributive Hyperkalemia
Metabolic acidosis
Dehydration
Massive tissue hypoxia
Insulin deficiency
Rhabdomyolysis
Severe burns
Tumor lysis syndrome
Epilepticus
Fluoride poisoning
Iatrogenic
Digitalis/Digoxin toxicity
B-adrenergic blockers
Chemotherapy agents (mitomycin-C, methotrexate, platinum compounds)
51
Hyperkalemia
Retentive Hyperkalemia
Decreased K+ excretion
Mineralocorticoid deficiency
Addison’s disease
Hyporeninemic hypoaldosteronism
ACE inhibitors
Primary renal tubule defect
Obstructive nephropathy
Renal transplant
Sickle cell disease
Systemic lupus erythematosus
K+ sparing diuretics (triamterene, amiloride, spironolactone)
Immunosuppressants (Tacrolimus, Cyclosporine)
Oliguria plus increased K+ load
Massive blood transfusion
Hemolysis
Tissue necrosis
High-dose penicillin
52
Hyperkalemia
Pseudohyperkalemia
Hemolysis
Thrombocytosis
Leukocytosis plus delayed transport or serum-cell separation
Fist pumping during venipuncture
53
Potassium Determination
Direct/Indirect ISE : valinomycin gel
Most widely used
AAS
FES – obsolete
Spectrophotometry
Pyruvate Kinase-Lactate dehydrogenase
Based on K+ activation of pyruvate
Substrate : Phosphoenolpyruvate
Measures disappearance of NADH
Measure decrease in absorbance at 380 nm
54
Chloride
Major extracellular anion
Limiting ion for the reabsorption of Na+
Chief counterion of Na+
Counter-exchange ion of HCO3-
(chloride shift)
Cornerstone for management of acid-base
imbalances
Only anion that has an enzyme-cofactor
function
Amylase
Reference Interval
98 – 107 mmol/L
55
Hypochloremia
Plasma chloride < 98 mmol/L
Causes
Hyponatremia and those associated with it
Prolonged vomiting
Metabolic Alkalosis
Compensated Respiratory Acidosis (normal sodium)
Increased bicarbonate = increased chloride shift
56
Hyperchloremia
Plasma chloride > 107 mmol/L
Causes
Hypernatremia and those associated with it
Metabolic Acidosis
Salicylate intoxication
Compensated Respiratory Alkalosis (normal sodium)
Decreased bicarbonate = decreased chloride shift
57
Chloride Determination
Direct / Indirect ISE : tri-n-octylpropylammonium chloride
Most commonly used
Mercurimetric Titration (Schales and Schales Method)
Indicator : Diphenylcarbazone
End-product : HgCl2 (blue-violet)
Amperostatic Coulometry
Replaced by ISE ; still used for sweat chloride analysis
Spectrophotometry
Whitehorn Titration (Mercuric thiocyanate) – formation of red complex
Ferric Perchlorate : formation of yellow Iron(III)-chloride complex
Iwasaki-Utsumi-Ozawa : Formation of red-orange complex Fe(CNS)2+
Common interferants in all methods
Thiocyanates, other Halide ions
Bone and Mineral
Metabolism
59
Calcium
Most abundant cation in the body
99% in skeleton
1% in ECF and Soft Tissues
Distribution in plasma
50% - ionized; biologically active form
40% - protein-bound (80% albumin)
10% - complexed
Hormone Regulators
PTH : hypercalcemic hormone
Calcitonin : hypocalcemic hormone; secreted by parafollicular C cells
Reference intervals
Total Ca2+ : 2.15 – 2.50 mmol/L (8.6 – 10.0 mg/dL)
Serum iCa2+: 1.16 – 1.32 mmol/L (4.6 – 5.3 mg/dL)
Plasma iCa2+ : 1.03 – 1.23 mmol/L (4.1 – 4.9 mg/dL)
62
Hypocalcemia
Total plasma Ca2+ < 2.15 mmol/L
Increases neuromuscular excitability
Signs and symptoms (usually when Total Ca2+ drops below 1.88 mmol/L)
Parasthesia : circumoral, peripheral, perianal
Neuromuscular irritability : weakness, twitching, cramps, tetany
Laryngospasm and bronchospasm in severe cases
Fatigue
Cataracts
Cardiac : hypotension, arrhythmia as, ECG abnormalities, CHF
CNS abnormalities
Depression
Alerted mental status
Seizures
Coma
63
Hypocalcemia
Artefactual
Hypoalbuminemia – most common cause
1 g/dL albumin binds 0.02 mmol/L Ca2+
Normal ionized calcium
Usage of EDTA or Citrate in venipuncture
Gadolinium salts
Excessive or rapid infusion of IV Fluids
64
Hypocalcemia
Diseases
Chronic Kidney Disease
Hyperphosphatemia, PTH resistance, Decreased Calcitriol
Hypoparathyroidism
Pseudohypoparathyroidism
Activating CaSR mutations
Osteoblastic metastasis
Hungry Bone syndrome – healing phase
Post-parathyroidectomy, post-thyroidectomy, treatment of hematologic
malignancies
65
Hypocalcemia
Calcium deposition in Tissues
Crush injury
Rhabdomyolysis
Hemorrhagic and edematous Pancreatitis
Tumor lysis syndrome
Vitamin D Deficiency or Resistance
Lack of sunlight exposure
Nutritional deficiency
Malabsorption
Gastric bypass surgery
End-stage liver disease
CKD
Vit. D-dependent rickets types 1 and 2
66
Hypocalcemia
Toxicities
Drugs
Biphosphonates
Deosumab
Imatinib
Proton pump inhibitors
Phosphate enemas
Foscarnet
Aluminum toxicity
Iron overload
Copper toxicity
67
Hypercalcemia
Total Plasma Ca2+ > 2.50 mmol/L
Signs and symptoms
Gastrointestinal Renal
nausea / Vomiting Polyuria
Abdominal pain Dehydration
hyperacidity Prerenal uremia
Peptic ulcers Stone formation
Constipation Tissue Calcification
Pancreatitis Nephrocalcinosis
Neurologic Vascular
Weakness Cardiac
Fatigue Cornea (band keratopathy)
Decreased muscle contaction Gastric mucosa
Depression Cardiac
Obtundation Prolonged Q-T interval in ECG
coma Decreased muscle contraction
68
Hypercalcemia
Primary Hyperparathyroidism
Adenoma, Hyperplasia, Carcinoma
Familial
Familial Benign Hypercalcemic Hypocalciuria
PTH normal ; Clinically welll with normal renal function ; CaCl/CrCl =
<0.01
Neonatal severe PHPT
Multiple endocrine neoplasia
Hyperparathyroidism Jaw Tumor syndrome
Familial isolated PHPT
Malignancies
Local osteolytic hypercalcemia – with skeletal involvement
Humoral hypercalcemia – no skeletal involvement
69
Hypercalcemia
Pheochromocytoma
Acute adrenal insufficiency
Acromegaly
Thyroidism
Idiopathic Hypercalcemia of Infancy
Loss of Function mutations in CYP24A1 (25-Hydroxylvitamin D 24-hydroxylase)
Vitamin overdose (D and A)
Granulomatous Disease
Sarcoidosis, Tuberculosis, Berylliosis, Coccidioidomycosis
Renal Failure
CKD, AKI
70
Hypercalcemia
Milk-Alkali syndrome
End-stage liver disease
Multiple myeloma
Manganese intoxication
artificial nutrition (TPN)
Drugs
Calcium and Vitamin D and its analogs
PTH therapy
Estrogen or selective estrogen receptor modulators
Lithium
Growth hormone
Aminophylline / Theophylline
Chlorothiazide diuretics
71
Phosphate
Predominant intracellular anion
Exists in organic and inorganic forms
Only inorganic (H2PO4- and HPO42-) forms are measured
physiological pH ratio 1:4
Ratio 1:1 in acidic pH ; 1:9 in alkaline pH
Affected by circadian rhythm
Peak : evening after dinner
Nadir : early morning
FGF23 – mid to long-term modulator of phosphate homeostasis
Increases fractional excretion of phosphates in kidneys
Decreases production of calcitriol by inhibiting 25-hydroxyvitamin D 1-alpha-hydroxylase)
Secreted by bone cells
Responsiveness declines with kidney failure
Reference Interval
0.78 – 1.42 mmol/L
75
Hypophosphatemia
Serum inorganic phosphate < 0.78mmol/L
Relatively common in hospitalized patients
Not necessarily associated with intracellular depletion
Causes
Intracellular shift – common
Lowered Renal Phosphate Threshold
Decreased Net Intestinal Phosphate Absorption
Intracellular Loss
Drugs
76
Hypophosphatemia
Intracellular Shift
Refeeding syndrome – anabolic state when refeeding malnourished
Glucose / Fructose, Insulin – major cause
Diabetic ketoacidosis
Respiratory alkalosis – accelerates glycolysis
Alcoholism
Severe burns
Hungry bone syndrome
Renal Wasting
Hyperparathyroidism
Oncogenic osteomalacia
Renal tubular defects
Familial hypophosphatemia
Fanconi syndrome
X-linked hypophosphatemic rickets (XLH)
77
Hypophosphatemia
Inadequate Net Intestinal Absorption
Increased loss
Vomiting and diarrhea
Aluminum / magnesium containing antacids
Decreased absorption
Malabsorption syndrome
Vitamin D syndrome
Intracellular Loss
Acidosis
Hypophosphatemic Rickets – X-linked, Autosomal dominant, autosomal recessive
Dent disease
Vitamin D-resistant rickets
78
Acetazolimide Estrogens
Anticonvulsants Ilfosamide
anti-EGF Iron polymaltose
HIV therapy Niacin
Azacitidine Paracetamol
Bisphosphonates Rapamycin
Catecholamines Salicylate
Cefottan Suramin
Diuretics Tyrosine-kinase inhibitors
79
Hyperphosphatemia
Serum inorganic phosphate > 1.42 mmol/L
Causes
Decreased Renal excretion
Increased Intake / Absorption
Increased Extracellular Load
Cell Lysis
Genetic
80
Hyperphosphatemia
Decreased RenalExcretion – most common cause
Decreased GFR : Renal Failure
Increased Tubular Reabsorption
Hypoparathyroidism
Pseudohypoparathyroidism
Acromegaly
Disodium etidronate
Increased extracellular Load
Transcellular shift
Acidosis
Untreated DKA
Malignant Hyperpyrexia
Increased Intake
Oral or IV
Laxatives or enemas
Vitamin D and its analogs
81
Hyperphosphatemia
Cell Lysis
Rhabdomyolysis
Intravascular hemolysis
Cytotoxic therapy
Tumor lysis syndrome
Leukemia
Lymphoma
Genetic
Tumoral calcinosis
Blomstrand disease
Epidermal naevus syndrome
osteoglophonic dysplasia
82
Phosphate Determination
Spectrophotometric
Fiske Subbarow Method
Most commonly used
Reagent : Ammonium molybdate
Formation of colorless phosphomolybdate complex measured at 340 nm
Carried at acidic pH
Fiske Subbarow with Reduction
Complex is reduced to molybdenum blue using
Pitcol (aminonaphthol sulfonic acid) - most common
Semidine (N-phenyl-p-phenyldoamine HCl)
Stannous chloride – provides greater color intensity
Measured at 600 – 700 nm
Magnesium
2nd most prevalent intracellular cation
Distribution
55% - skeleton
45% - other tissues
<1% - blood
55% - free
30% - protein-bound
15% - complexed
Competitive inhibitor of Ca in the presynaptic nerve terminals
Vasodilator
Reference Intervals
Total serum Mg2+ : 0.66 – 1.07 mmol/L (1.7-2.4 mg/dL)
Free serum Mg2+ : instrument dependent
84
Hypomagnesemia
Common among hospitalized patients, mostly those in the ICUs
May cause neuromuscular hyperexcitability with tetany and seizures.
Gastrointestinal Disorders
Prolonged nasogastric suction
Malabsorption syndrome
Extensive bowel resection
Diarrhea
Fistulas
Acute hemorrhagic pancreatitis
Celiac disease
Primary hypomagnesemia (neonatal)
Renal loss
Osmotic diuresis
Glucose
Mannitol
Urea
Chronic parenteral therapy
85
Hypomagnesemia
Hypercalcemia
Phosphate depletion
Drugs – mainly alcohol and diuretics
Aminoglycosides
Proton pump inhibitors
Cardiac glycosides
Cisplastin
Cyclosporine
Amphotericin B
Pentamidin
Metabolic acidosis
Genetics
Barrter syndrome
Gittelman syndrome
86
Hypermagnesemia
Rarely encountered
Mainly caused by excessive intake
other causes
Chronic Renal Failure
Rhabdomyolysis associated with acute renal failure
Familial Benign hypocalciuric hypercalcemia
Lithium ingestion
87
Magnesium Determination
Colorimetric
Calmagite
formation of red-violet complex in alkaline pH measured at 530-550 nm
EGTA is used to chelate Ca
Formazan Dye
Formation of colored complex at alkaline pH measured at 630 nm using dry-slide
reflectance photometry
BAPTA is used to chelate calcium
Methylthymol Blue
Formation of blue complex measured at 600 nm
Magon or Xylidyl blue
Red complex at alkaline pH measured at 600 nm
AAS – reference method
Dye-Lake Method
Titan Yellow Dye
88
REFERENCES
Bishop, M. L., Fody, E. P., Schoeff, L. E. (2018). Clinical chemistry: Principles,
techniques, and correlations.
Cheng, S., Schindler, E., & Scott, M. (2018) Disorders of Water, Electrolytes, and Acid-
Base Metabolism. In Rifai, N., Horvath, A. R., & Wittwer, C. (Eds), Tietz
Textbook of Clinical Chemistry and Molecular Diagnostics (6th ed., pp.1324-
1333). Elsevier.
Fraser, W. (2018) Bone and Mineral Metabolism. In Rifai, N., Horvath, A. R., & Wittwer, C.
(Eds), Tietz Textbook of Clinical Chemistry and Molecular Diagnostics (6th ed.,
pp.1422-1448). Elsevier.
Schindler, E., Brown, S., & Scott, M. (2018) Electrolytes and Blood Gases. In Rifai, N.,
Horvath, A. R., & Wittwer, C. (Eds), Tietz Textbook of Clinical Chemistry and
Molecular Diagnostics (6th ed., pp.604-615). Elsevier.